HealthEquity, Inc. (NASDAQ:HQY) Director Frank Medici sold 537,102 shares of the stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $51.24, for a total transaction of $27,521,106.48. Following the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at $326,962.44. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Frank Medici also recently made the following trade(s):
- On Thursday, July 13th, Frank Medici sold 131,800 shares of HealthEquity stock. The stock was sold at an average price of $51.42, for a total transaction of $6,777,156.00.
- On Wednesday, July 12th, Frank Medici sold 332,511 shares of HealthEquity stock. The stock was sold at an average price of $51.13, for a total transaction of $17,001,287.43.
- On Friday, July 7th, Frank Medici sold 186,749 shares of HealthEquity stock. The stock was sold at an average price of $50.26, for a total transaction of $9,386,004.74.
- On Wednesday, July 5th, Frank Medici sold 23,649 shares of HealthEquity stock. The stock was sold at an average price of $50.27, for a total transaction of $1,188,835.23.
- On Wednesday, June 21st, Frank Medici sold 154,265 shares of HealthEquity stock. The stock was sold at an average price of $51.94, for a total transaction of $8,012,524.10.
- On Wednesday, June 14th, Frank Medici sold 210,906 shares of HealthEquity stock. The stock was sold at an average price of $52.03, for a total transaction of $10,973,439.18.
HealthEquity, Inc. (HQY) traded down 2.62% on Friday, hitting $44.93. 579,253 shares of the stock traded hands. The company has a market capitalization of $2.69 billion, a PE ratio of 84.45 and a beta of 1.73. HealthEquity, Inc. has a 12 month low of $28.39 and a 12 month high of $54.95. The firm has a 50-day moving average price of $48.92 and a 200-day moving average price of $46.14.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.16 by $0.03. The firm had revenue of $55.40 million during the quarter, compared to analyst estimates of $54.77 million. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. HealthEquity’s revenue was up 25.9% on a year-over-year basis. During the same period last year, the firm posted $0.15 EPS. Analysts forecast that HealthEquity, Inc. will post $0.58 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “Frank Medici Sells 537,102 Shares of HealthEquity, Inc. (HQY) Stock” was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.com-unik.info/2017/08/11/healthequity-inc-hqy-director-frank-medici-sells-537102-shares-updated-updated-updated.html.
Several analysts have recently weighed in on the stock. Cantor Fitzgerald raised their price objective on shares of HealthEquity from $50.00 to $55.00 and gave the company an “overweight” rating in a research report on Wednesday, June 7th. Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $61.00 price objective (up previously from $57.00) on shares of HealthEquity in a research report on Monday, June 12th. BidaskClub lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a report on Wednesday, July 12th. Finally, Chardan Capital increased their target price on shares of HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a report on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $50.22.
Institutional investors have recently bought and sold shares of the company. BlackRock Inc. raised its position in HealthEquity by 157,852.9% in the first quarter. BlackRock Inc. now owns 5,589,953 shares of the company’s stock worth $237,293,000 after buying an additional 5,586,414 shares in the last quarter. FMR LLC raised its position in HealthEquity by 45.6% in the second quarter. FMR LLC now owns 2,235,150 shares of the company’s stock valued at $111,378,000 after buying an additional 699,728 shares during the period. TimesSquare Capital Management LLC purchased a new position in HealthEquity during the second quarter valued at $25,822,000. Norges Bank purchased a new position in HealthEquity during the fourth quarter valued at $14,203,000. Finally, Henderson Group PLC purchased a new position in HealthEquity during the first quarter valued at $12,323,000. 90.26% of the stock is owned by institutional investors.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
What are top analysts saying about HealthEquity Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthEquity Inc. and related companies.